Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla OXA-51-like sequence based typing

BMC Microbiology

Volumn 15, Issue 1, 2015, Pages

  Rafei, Rayane ^a,b   Pailhoriès, Hélène ^a   Hamze, Monzer ^b   Eveillard, Matthieu ^a   Mallat, Hassan ^b   Dabboussi, Fouad ^b   Joly Guillou, Marie Laure ^a   Kempf, Marie ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Acinetobacter baumannii; bla OXA 51 sequence based typing; Carbapenem resistance; Lebanon; MLST; NDM 1; OXA 23

Indexed keywords

CARBAPENEM; BETA LACTAMASE; BETA-LACTAMASE OXA-51, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLANDM 1 GENE; BLAOXA 51 LIKE GENE; BLAOXA 66 GENE; BLAOXA 69 GENE; CHILD; FEMALE; GENE INSERTION; GENETIC VARIABILITY; HOSPITAL; HUMAN; INFANT; LEBANESE; LEBANON; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SYRIAN; WOUND; ACINETOBACTER INFECTIONS; CLASSIFICATION; CROSS INFECTION; DNA SEQUENCE; ENZYMOLOGY; GENETIC VARIATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; CROSS INFECTION; GENETIC VARIATION; GENOTYPE; HOSPITALS; HUMANS; LEBANON; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84930639133     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-015-0441-5     Document Type: Article

References (49)

1. Joly-Guillou M-L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868-73.
2. Kempf M, Rolain J-M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39:105-14.
3. Hsueh P-R, Teng L-J, Chen C-Y, Chen W-H, Yu C-J, Ho S-W, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002;8:827-32.
4. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis. 2014;78:443-8.
5. Bonnin RA, Nordmann P, Poirel L. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther. 2013;11:571-83.
6. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex Polymerase Chain Reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2010;35:305-14.
7. Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57:2121-6.
8. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-Type carbapenemases in Gram-negative bacteria. BioMed Res Int. 2014;2014:249856.
9. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41:11-9.
10. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5, e10034.
11. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4328-35.
12. Nemec A, Dijkshoorn L, van der Reijden TJK. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol. 2004;53:147-53.
13. Higgins, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65:233-8.
14. Rafei R, Kempf M, Eveillard M, Dabboussi F, Hamze M, Joly-Guillou M-L. Current molecular methods in epidemiological typing of Acinetobacter baumannii. Future Microbiol. 2014;9:1179-94.
15. Bartual SG, Seifert H, Hippler C, Luzon MAD, Wisplinghoff H, Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4382-90.
16. Hamouda A, Evans BA, Towner KJ, Amyes SGB. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of blaOXA-51-like genes. J Clin Microbiol. 2010;48:2476-83.
17. Park YK, Jung S-I, Park K-H, Cheong HS, Peck KR, Song J-H, et al. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis. 2009;64:43-51.
18. Zander E, Nemec A, Seifert H, Higgins PG. Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J Clin Microbiol. 2012;50:1900-4.
19. Pournaras S, Gogou V, Giannouli M, Dimitroulia E, Dafopoulou K, Tsakris A, et al. Single locus sequence-based typing of blaOXA-51-like gene for rapid classification of Acinetobacter baumannii clinical isolates to international clones. J Clin Microbiol. 2014;52:1653-7.
20. Rafei R, Dabboussi F, Hamze M, Eveillard M, Lemarié C, Gaultier M-P, et al. Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS One. 2014;9, e115969.
21. Zarrilli R, Vitale D, Di Popolo A, Bagattini M, Daoud Z, Khan AU, et al. A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob Agents Chemother. 2008;52:4115-20.
22. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect. 2011;17:197-201.
23. Giannouli M, Tomasone F, Agodi A, Vahaboglu H, Daoud Z, Triassi M, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in Intensive Care Units of multiple Mediterranean hospitals. J Antimicrob Chemother. 2009;63:828-30.
24. Rafei R, Dabboussi F, Hamze M, Eveillard M, Lemarié C, Mallat H, et al. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int J Infect Dis. 2014;21:21-3.
25. Eveillard M, Kempf M, Belmonte O, Pailhoriès H, Joly-Guillou M-L. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013;17:e802-5.
26. O'Shea MK. Acinetobacter in modern warfare. Int J Antimicrob Agents. 2012;39:363-75.
27. Sheppard FR, Keiser P, Craft DW, Gage F, Robson M, Brown TS, et al. The majority of US combat casualty soft-tissue wounds are not infected or colonized upon arrival or during treatment at a continental US military medical facility. Am J Surg. 2010;200:489-95.
28. Mugnier PD. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35-40.
29. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef APD, Asensi MD, et al. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio De Janeiro? J Antimicrob Chemother. 2011;66:62-5.
30. Principe L, Piazza A, Giani T, Bracco S, Caltagirone MS, Arena F, et al. Epidemic diffusion of OXA-23-producing Acinetobacter baumannii in Italy: results of the first cross-sectional countrywide survey. J Clin Microbiol. 2014;52:3004-10.
31. Evans BA, Amyes SGB. OXA β-Lactamases. Clin Microbiol Rev. 2014;27:241-63.
32. Zander E, Higgins PG, Fernández-González A, Seifert H. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int J Med Microbiol IJMM. 2013;303:88-9.
33. Lee Y-T, Turton JF, Chen T-L, Wu RC-C, Chang W-C, Fung C-P, et al. First identification of blaOXA-51-like in non-baumannii Acinetobacter spp. J Chemother Florence Italy. 2009;21:514-20.
34. Aly M, Tayeb HT, Al Johani SM, Alyamani EJ, Aldughaishem F, Alabdulkarim I, et al. Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis. 2014;33:1223-8.
35. Evans BA, Hamouda A, Towner KJ, Amyes SGB. OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect. 2008;14:268-75.
36. Karah N, Sundsfjord A, Towner K, Samuelsen Ø. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15:237-47.
37. Rafei R, Hamze M, Pailhoriès H, Eveillard M, Marsollier L, Joly-Guillou M-L, et al. Extrahuman Epidemiology of Acinetobacter baumannii in Lebanon. Appl Environ Microbiol. 2015;81:2359-67.
38. Decousser J, Jansen C, Nordmann P, Emirian A, Bonnin R, Anais L, et al. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill. 2013;18:20547.
39. Bonnin RA, Cuzon G, Poirel L, Nordmann P. Multidrug-resistant Acinetobacter baumannii clone, France. Emerg Infect Dis. 2013;19:822-3.
40. Revathi G, Siu LK, Lu P-L, Huang L-Y. First report of NDM-1-producing Acinetobacter baumannii in East Africa. Int J Infect Dis. 2013;17:e1255-8.
41. Belmonte O, Pailhoriès H, Kempf M, Gaultier MP, Lemarié C, Ramont C, et al. High prevalence of closely-related Acinetobacter baumannii in pets according to a multicentre study in veterinary clinics, Reunion Island. Vet Microbiol. 2014;170:446-50.
42. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Göttig S, Hunfeld K-P, et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66:1998-2001.
43. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, et al. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect. 2012;18:E362-5.
44. Kempf M, Rolain J-M, Diatta G, Azza S, Samb B, Mediannikov O, et al. Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs. PLoS One. 2012;7, e39495.
45. Gundi VAKB, Dijkshoorn L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009;155:2333-41.
46. Mesli E, Berrazeg M, Drissi M, Bekkhoucha SN, Rolain J-M. Prevalence of carbapenemase-encoding genes including New Delhi metallo-β-lactamase in Acinetobacter species, Algeria. Int J Infect Dis. 2013;17:e739-43.
47. Bonnin RA, Naas T, Poirel L, Nordmann P. Phenotypic, biochemical, and molecular techniques for detection of Metallo-?-Lactamase NDM in Acinetobacter baumannii. J Clin Microbiol. 2012;50:1419-21.
48. Hong SS, Kim K, Huh JY, Jung B, Kang MS, Hong SG. Multiplex PCR for rapid detection of genes encoding Class A carbapenemases. Ann Lab Med. 2012;32:359-61.
49. Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. Prevalence of IS(Aba1) in epidemiologically unrelated Acinetobacter baumannii clinical isolates. Clin Microbiol Infect. 2007;13:1192-8.